Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7617115rdf:typepubmed:Citationlld:pubmed
pubmed-article:7617115lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:7617115lifeskim:mentionsumls-concept:C0028754lld:lifeskim
pubmed-article:7617115lifeskim:mentionsumls-concept:C0033687lld:lifeskim
pubmed-article:7617115lifeskim:mentionsumls-concept:C0006938lld:lifeskim
pubmed-article:7617115lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7617115lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:7617115lifeskim:mentionsumls-concept:C1517945lld:lifeskim
pubmed-article:7617115pubmed:issue1lld:pubmed
pubmed-article:7617115pubmed:dateCreated1995-8-24lld:pubmed
pubmed-article:7617115pubmed:abstractTextWe have identified 17 obese patients (body mass index, BMI, 37.9 +/- 4.1) with proteinuria > 1 g/day (1.3-6.4 g/24 h, mean 3.1 +/- 1.7). Their age was 34-70 years (48.3 +/- 10); 11 were females and 6 males. Six patients had only one functioning kidney and a sleep apnea syndrome had been diagnosed in 5. Renal biopsies, obtained in 5 cases, showed focal glomerulosclerosis in 2 cases, minimal changes in 2 and mesangial proliferation in 1. Nine patients (group 1) were treated with hypocaloric diets; body weight significantly decreased (BMI 37.1 +/- 3, 34 +/- 3.5 and 32.6 +/- 3.2 at 0, 6 and 12 months, respectively) as well as proteinuria (2.9 +/- 1.7, 1.2 +/- 1 and 0.4 +/- 0.6 g/24 h). There was a significant correlation between body weight loss and decrease in proteinuria (r = 0.69, p < 0.05). Eight patients (group 2) were treated with captopril, without dietary changes. BMI remained stable but proteinuria showed a dramatic decrease, similar to that in group 1 (3.4 +/- 1.7, 1.2 +/- 0.9 and 0.7 +/- 1 g/24 h, respectively). Renal function remained stable in both groups. In summary, both body weight loss and captopril treatment can induce a sharp decrease in obesity-related proteinuria.lld:pubmed
pubmed-article:7617115pubmed:languageenglld:pubmed
pubmed-article:7617115pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7617115pubmed:citationSubsetIMlld:pubmed
pubmed-article:7617115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7617115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7617115pubmed:statusMEDLINElld:pubmed
pubmed-article:7617115pubmed:issn0028-2766lld:pubmed
pubmed-article:7617115pubmed:authorpubmed-author:RodicioJ LJLlld:pubmed
pubmed-article:7617115pubmed:authorpubmed-author:HernándezEElld:pubmed
pubmed-article:7617115pubmed:authorpubmed-author:RuilopeL MLMlld:pubmed
pubmed-article:7617115pubmed:authorpubmed-author:PragaMMlld:pubmed
pubmed-article:7617115pubmed:authorpubmed-author:AndrésAAlld:pubmed
pubmed-article:7617115pubmed:authorpubmed-author:LeónMMlld:pubmed
pubmed-article:7617115pubmed:issnTypePrintlld:pubmed
pubmed-article:7617115pubmed:volume70lld:pubmed
pubmed-article:7617115pubmed:ownerNLMlld:pubmed
pubmed-article:7617115pubmed:authorsCompleteYlld:pubmed
pubmed-article:7617115pubmed:pagination35-41lld:pubmed
pubmed-article:7617115pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:meshHeadingpubmed-meshheading:7617115-...lld:pubmed
pubmed-article:7617115pubmed:year1995lld:pubmed
pubmed-article:7617115pubmed:articleTitleEffects of body-weight loss and captopril treatment on proteinuria associated with obesity.lld:pubmed
pubmed-article:7617115pubmed:affiliationNephrology Department, Hospital 12 de Octubre, Madrid, Spain.lld:pubmed
pubmed-article:7617115pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7617115pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7617115pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7617115lld:pubmed